Your browser doesn't support javascript.
loading
WHO/IUIS Allergen Nomenclature: Providing a common language.
Pomés, Anna; Davies, Janet M; Gadermaier, Gabriele; Hilger, Christiane; Holzhauser, Thomas; Lidholm, Jonas; Lopata, Andreas L; Mueller, Geoffrey A; Nandy, Andreas; Radauer, Christian; Chan, Sanny K; Jappe, Uta; Kleine-Tebbe, Jörg; Thomas, Wayne R; Chapman, Martin D; van Hage, Marianne; van Ree, Ronald; Vieths, Stefan; Raulf, Monika; Goodman, Richard E.
Affiliation
  • Pomés A; Indoor Biotechnologies, Basic Research, Charlottesville, VA, USA.
  • Davies JM; School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia.
  • Gadermaier G; University of Salzburg, Dept. of Molecular Biology, Salzburg, Austria.
  • Hilger C; Luxembourg Institute of Health, Dept. of Infection and Immunity, Luxembourg, Luxembourg.
  • Holzhauser T; Paul-Ehrlich-Institute, Division of Allergology, Langen, Germany.
  • Lidholm J; Thermo Fisher Scientific, Uppsala, Sweden.
  • Lopata AL; James Cook University, Molecular Allergy Research Laboratory, Townsville, Queensland, Australia.
  • Mueller GA; National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.
  • Nandy A; ALLERGOPHARMA GmbH & Co. KG, Reinbek, Germany.
  • Radauer C; Medical University of Vienna, Dept. of Pathophysiology and Allergy Research, Vienna, Austria.
  • Chan SK; National Jewish Health, Dept. of Pediatrics, Div. of Allergy, Denver, CO, USA.
  • Jappe U; Division of Clinical and Molecular Allergology, ARCN, DZL, Research Center Borstel, Borstel, Germany.
  • Kleine-Tebbe J; Allergy & Asthma Center Westend, Outpatient Clinic & Clinical Research Center, Berlin, Germany.
  • Thomas WR; Telethon Kids Institute, University of Western Australia, WA, Australia.
  • Chapman MD; Indoor Biotechnologies, Basic Research, Charlottesville, VA, USA.
  • van Hage M; Karolinska Institute, Department of Medicine Solna, Immunology and Allergy Unit, Karolinska University Hospital, Stockholm, Sweden.
  • van Ree R; Academic Medical Center, Deptartments of Experimental Immunology and Otorhinolaryngology, Amsterdam, The Netherlands.
  • Vieths S; Paul-Ehrlich-Institute, Langen, Germany.
  • Raulf M; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum, Bochum, Germany.
  • Goodman RE; Food Allergy Research and Resource Program, University of Nebraska-Lincoln, Lincoln, NE, USA. Electronic address: rgoodman2@unl.edu.
Mol Immunol ; 100: 3-13, 2018 08.
Article in En | MEDLINE | ID: mdl-29625844
ABSTRACT
A systematic nomenclature for allergens originated in the early 1980s, when few protein allergens had been described. A group of scientists led by Dr. David G. Marsh developed a nomenclature based on the Linnaean taxonomy, and further established the World Health Organization/International Union of Immunological Societies (WHO/IUIS) Allergen Nomenclature Sub-Committee in 1986. Its stated aim was to standardize the names given to the antigens (allergens) that caused IgE-mediated allergies in humans. The Sub-Committee first published a revised list of allergen names in 1986, which continued to grow with rare publications until 1994. Between 1994 and 2007 the database was a text table online, then converted to a more readily updated website. The allergen list became the Allergen Nomenclature database (www.allergen.org), which currently includes approximately 880 proteins from a wide variety of sources. The Sub-Committee includes experts on clinical and molecular allergology. They review submissions of allergen candidates, using evidence-based criteria developed by the Sub-Committee. The review process assesses the biochemical analysis and the proof of allergenicity submitted, and aims to assign allergen names prior to publication. The Sub-Committee maintains and revises the database, and addresses continuous challenges as new "omics" technologies provide increasing data about potential new allergens. Most journals publishing information on new allergens require an official allergen name, which involves submission of confidential data to the WHO/IUIS Allergen Nomenclature Sub-Committee, sufficient to demonstrate binding of IgE from allergic subjects to the purified protein.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Allergens Limits: Animals / Humans Language: En Journal: Mol Immunol Year: 2018 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Allergens Limits: Animals / Humans Language: En Journal: Mol Immunol Year: 2018 Document type: Article Affiliation country: